The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2017
Filed:
Jul. 12, 2016
Applicant:
Lupin Limited, Mumbai, Maharashtra, IN;
Inventors:
Ashish Ashokrao Deshmukh, Maharashtra, IN;
Pravin Meghrajji Bhutada, Maharashtra, IN;
Sajeev Chandran, Maharashtra, IN;
Shirishkumar Kulkarni, Maharashtra, IN;
Assignee:
LUPIN LIMITED, Mumbai, Maharashtra, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 31/4545 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0053 (2013.01); A61K 9/0004 (2013.01); A61K 9/209 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2072 (2013.01); A61K 9/2086 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01); A61K 31/4545 (2013.01);
Abstract
The present invention relates to oral controlled release pharmaceutical compositions comprising Bepotastine. The oral controlled release pharmaceutical composition comprises Bepotastine or pharmaceutically acceptable salts thereof and at least one release controlling agent. The present invention also provides the use of oral controlled release pharmaceutical compositions of Bepotastine for the treatment of allergic rhinitis and for the treatment of pruritus caused by urticaria.